This research service presents an overview of the South Korean biosimilars market and analyzes the opportunities that lay ahead for different stakeholders in the development, manufacturing, and commercialization of biosimilars. This service divides the market into therapeutic proteins and monoclonal antibodies. Further, it aims to present an overview of the global biosimilars market and covers impending patent expiries for biologics, regulatory guidelines, pipeline data, and important participants in the market. Moreover, key market challenges, drivers, and restraints are discussed. The forecast period extends through 2015, with a base year of 2010.